Vir Biotechnology Inc (VIR)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) ratio for Vir Biotechnology Inc for various quarters from March 2020 to December 2024 is not provided in the data. DSO is a measure of how many days it takes for a company to collect revenue after a sale is made. It is calculated by dividing accounts receivable by average daily sales.
Without the specific DSO values for Vir Biotechnology Inc, it is challenging to assess the efficiency of the company in collecting its accounts receivable. A lower DSO is generally preferred as it indicates faster collections and better liquidity. On the other hand, a high DSO may imply inefficiencies in the company's credit policies or difficulties in collections.
To make a more thorough analysis of Vir Biotechnology Inc's DSO, it would be necessary to have the actual DSO values for the provided dates to track trends over time and compare them against industry averages or company benchmarks. Monitoring DSO can provide insights into the company's financial health, profitability, and potential cash flow issues.
Peer comparison
Dec 31, 2024